Fact Source: Financial Supervisory Service DART
💡 3-Second Summary
ALTEOGEN will participate in the ‘2026 BofA Korea Conference’ sponsored by Bank of America at the Grand Hyatt Hotel to hold 1-on-1 and group meetings with foreign institutional investors regarding its business status and R&D progress.
📊 [Key Disclosure Details & Major Figures Summary]
- Event Name: 2026 BofA Korea Conference Participation (One-on-One & Group Meetings)
- Date & Time: June 17, 2026, 09:00 – 12:00 (Local Time)
- Location: Grand Hyatt Hotel
- Target Audience: Foreign institutional investors
- Purpose: To enhance understanding among foreign institutional investors by presenting company status, R&D progress, and growth strategies
- Method: One-on-One and Group Meetings via conference participation
- Key Details: Corporate presentation, business status, R&D progress, and Q&A
- Sponsoring Institution: Bank of America
- Confirmation Date: June 16, 2026
- Contact Department: IR Team (Tel: +82-42-384-8777)
- IR Material Publication: Scheduled for publication on June 17, 2026, on the KRX KIND system website (http://kind.krx.co.kr)
📝 Editor’s Comment (Key Follow-up Checkpoint)
📌 Verification of Corporate R&D and Growth Strategies via Published IR Materials
The company plans to publish its IR materials on the KRX KIND system on June 17, 2026, for this event. Reviewing the official presentation materials provided to foreign institutional investors is essential because it allows investors to accurately understand the company’s latest R&D status and strategic direction. Detailed contents can be cross-checked in the official IR presentation materials published on the KRX KIND system website.
📢 Disclaimer & Source Notice
Source: This content has been structured and newly created based on official filing data from the Financial Supervisory Service (DART).
Investment Risk Notice: This content is provided for informational and language reference purposes only. Under no circumstances does it constitute financial advice or a recommendation to buy or sell any specific stock. All investment decisions and financial responsibilities rest entirely with the investor.
Contact: For compliance inquiries or copyright requests, please contact ksb220805@gmail.com.
